ATE125805T1 - Furanderivate. - Google Patents
Furanderivate.Info
- Publication number
- ATE125805T1 ATE125805T1 AT90115731T AT90115731T ATE125805T1 AT E125805 T1 ATE125805 T1 AT E125805T1 AT 90115731 T AT90115731 T AT 90115731T AT 90115731 T AT90115731 T AT 90115731T AT E125805 T1 ATE125805 T1 AT E125805T1
- Authority
- AT
- Austria
- Prior art keywords
- furan derivatives
- gastrointestinal
- enterokinetic
- expected
- activity
- Prior art date
Links
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical class C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 title 1
- 230000002496 gastric effect Effects 0.000 abstract 2
- 208000012661 Dyskinesia Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002240 furans Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21192089 | 1989-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE125805T1 true ATE125805T1 (de) | 1995-08-15 |
Family
ID=16613857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90115731T ATE125805T1 (de) | 1989-08-17 | 1990-08-16 | Furanderivate. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5075301A (de) |
| EP (1) | EP0413343B1 (de) |
| JP (1) | JPH0730064B2 (de) |
| AT (1) | ATE125805T1 (de) |
| CA (1) | CA2023311C (de) |
| DE (1) | DE69021294T2 (de) |
| DK (1) | DK0413343T3 (de) |
| ES (1) | ES2075098T3 (de) |
| GR (1) | GR3017870T3 (de) |
| HK (1) | HK1006459A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9009437D0 (en) * | 1990-04-26 | 1990-06-20 | Glaxo Group Ltd | Chemical compounds |
| US5338871A (en) * | 1991-12-20 | 1994-08-16 | Torcan Chemical Ltd. | Preparation of form 1 ranitidine hydrochloride |
| AU662454B2 (en) * | 1992-05-12 | 1995-08-31 | Zeria Pharmaceutical Co., Ltd. | Novel quaternary ammonium salts and use thereof as medicine |
| CA2219747C (en) * | 1995-05-18 | 2008-11-25 | Zeria Pharmaceutical Co., Ltd. | Aminothiazole derivative, medicament containing the same, and intermediate for preparation of said compound |
| US6121301A (en) * | 1996-10-24 | 2000-09-19 | Zeria Pharmaceutical Co., Ltd. | Substituted benzoylaminothiazole derivatives and drugs containing the same |
| US6152966A (en) * | 1998-05-13 | 2000-11-28 | Novo Nordisk A/S | Treatment of cork with a phenol oxidizing enzyme |
| US6362205B2 (en) | 1998-11-05 | 2002-03-26 | Novo Nordisk A/S | Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| AU6327199A (en) | 1998-11-05 | 2000-05-29 | Novo Nordisk A/S | Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| KR20060123210A (ko) * | 2003-12-04 | 2006-12-01 | 에프엠씨 코포레이션 | 살충성 ｎ-(헤테로아릴알킬)알칸다이아민 유도체 |
| CN111303087B (zh) * | 2020-04-07 | 2021-08-10 | 自然资源部第三海洋研究所 | 呋喃酮类化合物及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4048058A (en) * | 1975-08-13 | 1977-09-13 | Standard Oil Company (Indiana) | Methods to be used in reforming processes employing multi-metallic catalysts |
| GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
| FI832520A7 (fi) * | 1982-07-12 | 1984-01-13 | Bristol Myers Co | Farmaseuttisia menetelmiä ja koostumuksia. |
| US4458077A (en) * | 1982-11-22 | 1984-07-03 | American Home Products Corporation | Heterocyclic anti-ulcer agents |
| GB2209163B (en) * | 1987-08-28 | 1991-04-24 | Toyama Chemical Co Ltd | Amine derivative and its salt, process for producing the same, and anti-ulcer agent containing the same |
-
1990
- 1990-08-10 JP JP21183690A patent/JPH0730064B2/ja not_active Expired - Fee Related
- 1990-08-14 US US07/567,182 patent/US5075301A/en not_active Expired - Lifetime
- 1990-08-15 CA CA002023311A patent/CA2023311C/en not_active Expired - Fee Related
- 1990-08-16 EP EP90115731A patent/EP0413343B1/de not_active Expired - Lifetime
- 1990-08-16 DE DE69021294T patent/DE69021294T2/de not_active Expired - Fee Related
- 1990-08-16 ES ES90115731T patent/ES2075098T3/es not_active Expired - Lifetime
- 1990-08-16 DK DK90115731.3T patent/DK0413343T3/da active
- 1990-08-16 AT AT90115731T patent/ATE125805T1/de not_active IP Right Cessation
-
1995
- 1995-10-25 GR GR950402974T patent/GR3017870T3/el unknown
-
1998
- 1998-06-19 HK HK98105755A patent/HK1006459A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2023311C (en) | 1999-11-02 |
| EP0413343A2 (de) | 1991-02-20 |
| DE69021294D1 (de) | 1995-09-07 |
| EP0413343B1 (de) | 1995-08-02 |
| JPH03163074A (ja) | 1991-07-15 |
| JPH0730064B2 (ja) | 1995-04-05 |
| US5075301A (en) | 1991-12-24 |
| EP0413343A3 (en) | 1992-04-22 |
| GR3017870T3 (en) | 1996-01-31 |
| DE69021294T2 (de) | 1996-01-25 |
| CA2023311A1 (en) | 1991-02-18 |
| HK1006459A1 (en) | 1999-02-26 |
| ES2075098T3 (es) | 1995-10-01 |
| DK0413343T3 (da) | 1995-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU90219I2 (fr) | Tolcapone et ses dérivés pharmaceutiquement acceptables (TASMAR) | |
| LU91039I2 (fr) | Proteq flu et ses dérivés pharmaceutiquement acceptables | |
| LV10442A (lv) | Panemiens pirimidina atvasinajumu iegusanai | |
| KR870700602A (ko) | 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도 | |
| LU90484I2 (fr) | Novorapid - insuline asparte et ses sels et derives pharmaceutiquement acceptables | |
| LV10082A (lv) | Propenskabes atvasinajumi to iegusanas panemiens sastavs un pielietosana senisu kukainu un ercu apkarosanai | |
| LU88790I2 (fr) | Moxidectin et ses dérivés pharmaceutiquement acceptables | |
| DE69021294D1 (de) | Furanderivate. | |
| KR910700046A (ko) | 포르피린의 생산 및 용도 | |
| FI895447A7 (fi) | Substituoidut terapeuttisina aineina käytettävät adeniinijohdannaiset | |
| FI924478L (fi) | 24-oxa-derivat i vitamin d-serien | |
| FR2623806B1 (fr) | Esters d'acides 3,6-dihydro-1,5(2h)-pyrimidinecarboxyliques a action therapeutique | |
| LU88843I2 (fr) | Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R) | |
| LV10436A (lv) | Azola atvasinajumi un to iegusanas starpprodukti | |
| LV10074A (lv) | Aizvietoti bicikloheptadiona atvasinajumi un to iegusanas panemiens un herbicidi | |
| IT8822760A0 (it) | Ciclodestrinclatrati di derivati della 5-ciano-prostaciclina e loro impiego come medicinali | |
| JPS5419959A (en) | Novel daunobicine derivative * production thereof and use of same as drug | |
| DK329189A (da) | Glycerolderivat og dets farmakologiske anvendelse | |
| SE7902915L (sv) | 4-oxo-4h-pyrido(1,2-a)pyrimidin-3-n-(1h-tetrazol-5-yl) karboxamidderivat och deras anvendning sasom inhibitorer av allergiska reaktioner | |
| LU90110I2 (fr) | Penciclovir et ses dérivés pharmaceutiquement acceptables | |
| BE859290A (fr) | Preparation d'acides alpha-cetocarboxyliques aliphatiques et heterocycliques | |
| DK283586D0 (da) | Penemderivater | |
| FI893233A7 (fi) | THAZ-johdannaisia aivotoiminnan parantamiseksi | |
| KR920007626A (ko) | 벤조[b]티오펜-2-카르복시이미드아미드 유도체의 사용방법 | |
| IT1095602B (it) | Derivati d'acidi furoil-o tenoil-naftilossialchil-carbossilio i,loro preparazione e loro impiego come medicamenti |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |